Part III MARKETING ORGANISMS
- 14Requirement for consent to market
- 15Exempt activities
- 16Applications for consent to market
- 17Transitional provisions for marketing
- 17ATransitional measures for adventitious or technically unavoidable presence of genetically modified material which has benefited from a favourable risk evaluation.
- 18Applications for renewal of consent to market